Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

Authors: Joon H. Uhm, Karla V. Ballman, Wenting Wu, Caterina Giannini, John C. Krauss, Jan C. Buckner, C. David James, Bernd W. Scheithauer, Robert J. Behrens, Patrick J. Flynn, Paul Schaefer, Shaker R. Dakhill, Kurt A. Jaeckle - International Journal of Radiation Oncology*Biology*Physics 2010 cited by 186